ストックスクリーナーアプリを入手
1.36
0.00%
0.00
Quince Therapeutics Inc (QNCX) 最新ニュース
Quince Therapeutics settles $16.4M debt with $5.5M payment - MSN
Why is QNCX stock up 60% pre-market after a near-total wipeout? - MSN
Why did QNCX stock plummet over 90% today? - MSN
Quince Therapeutics Appoints June Bray to Board - The Globe and Mail
Quince Therapeutics appoints June Bray to board of directors - Investing.com
Quince Therapeutics appoints June Bray to board of directors By Investing.com - Investing.com UK
[8-K] Quince Therapeutics, Inc. Reports Material Event - Stock Titan
QNCX Stock Price, Quote & Chart | QUINCE THERAPEUTICS INC (NASDAQ:QNCX) - ChartMill
Quince Therapeutics (QNCX) Stock: Worth Entering? (-6.93%) 2026-04-20Top Breakouts - Cổng thông tin điện tử Tỉnh Sơn La
QNCX Sees Increased Price Target Amidst Maintained Buy Rating | - GuruFocus
Quince Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Form S-8Securities to be offered to employees in employee benefit plans - ADVFN
Earnings Beat: Should I hold or sell Quince Therapeutics Inc now2026 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Treasury Yields: Whats Quince Therapeutics Incs historical returnMarket Trend Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Opening: Can Quince Therapeutics Inc sustain its profitabilityM&A Rumor & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Quince Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
QNCX: Lead asset failed in Phase 3, triggering strategic review and raising going concern risks - TradingView
Phase 3 miss leaves Quince Therapeutics (QNCX) chasing reverse merger path - Stock Titan
Quince Therapeutics Announces 1-for-10 Reverse Stock Split - The Globe and Mail
Quince Therapeutics To Carry Out 1-for-10 Reverse Stock Split On April 13th, 2026 - Moomoo
Quince Therapeutics to implement 1-for-10 reverse stock split effective Friday - Investing.com Australia
Quince Therapeutics, Inc. Files Form 8-K Announcing Certificate of Amendment and Company Details - Minichart
Quince Therapeutics to implement 1-for-10 reverse stock split effective Friday By Investing.com - Investing.com South Africa
Quince Therapeutics (QNCX) enacts 1-for-10 reverse split, 16.3M shares post-split - Stock Titan
Dow Jumps Over 1,300 Points; Delta Air Lines Shares Gain After Q1 Results - Sahm
US Market Preview | OMEX Up 148%; Iran CeasefireStocks, Gold Rally, Oil Dives; SpaceX-Tesla Merger Buzz Grows; DAL Surges 12% After Earnings - Sahm
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
9 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
History Review: Is Quince Therapeutics Inc stock overvalued or fairly pricedEarnings Recap Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
$Quince Therapeutics (QNCX.US)$ thanks 🤑🤑🤑 - Moomoo
$Quince Therapeutics (QNCX.US)$ goodluck guy - Moomoo
$Quince Therapeutics (QNCX.US)$ mon stop fight it - Moomoo
$Quince Therapeutics (QNCX.US)$ thank clear - Moomoo
$Quince Therapeutics (QNCX.US)$ awwww - Moomoo
$Quince Therapeutics (QNCX.US)$ - Moomoo
$Quince Therapeutics (QNCX.US)$ i just sold off my initial investment - Moomoo
Plays for 4-08-2026 $BTC Digital (BTCT.US)$ $Quince Therapeutics (QNCX.US)$ - Moomoo
still holding - Moomoo
Trending Stocks Today | U Power Surges 59.06% Post-Market - Moomoo
Wondering what's happening in today's after-hours session? - ChartMill
QNCX PE Ratio & Valuation, Is QNCX Overvalued - Intellectia AI
Quince Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView — Track All Markets
QNCX Stock Analysis: Quince Therapeutics Inc. 3.23% drop to $0.1, biotech performance assessment - UBND thành phố Hải Phòng
Will Quince Therapeutics (QNCX) Stock Miss Expectations | Price at $0.99, Down 3.23%Shared Buy Zones - UBND thành phố Hải Phòng
Quince Therapeutics Delays Annual 10-K Filing - TipRanks
Quince Therapeutics (QNCX) delays 2025 10-K after failed Phase 3; seeks 15-day extension - Stock Titan
QNCX Stock News Today | Earnings, Events & Price Alerts - intellectia.ai
Aug Setups: Will Quince Therapeutics Inc benefit from AI trends2026 Earnings & Fast Moving Trade Plans - baoquankhu1.vn
Quince Therapeutics settles $16.4M debt for $5.5M payment By Investing.com - Investing.com South Africa
Quince Therapeutics Eliminates EIB Debt, Boosts Flexibility - The Globe and Mail
Quince Therapeutics (QNCX) Resolves Debt with European Investmen - GuruFocus
Quince Therapeutics Settles $16.4 Million in Debt - National Today
4.01%
0.61%
大文字化:
|
ボリューム (24 時間):